Antibiotic prophylaxis in gastrointestinal endoscopy

Gut

Volumn 58, Issue 6, 2009, Pages 869-880

  Allison, M C ^a   Sandoe, J A T ^b   Tighe, R ^c   Simpson, I A ^d   Hall, R J ^c   Elliott, T S J ^e  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ASPIRATION PNEUMONIA; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL PERITONITIS; BILE DUCT OBSTRUCTION; BLOOD VESSEL GRAFT; CARDIOVASCULAR RISK; CHOLANGITIS; CLINICAL FEATURE; CYST INFECTION; DISEASE PREDISPOSITION; DRUG EFFICACY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION; INFECTION RISK; MEDICAL LITERATURE; MEDICAL PRACTICE; NEUTROPENIA; PANCREAS INJURY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PERISTOMAL INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEPSIS; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CIPROFLOXACIN; ENDOCARDITIS, BACTERIAL; ENDOSCOPY, GASTROINTESTINAL; GENTAMICINS; HUMANS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS;

EID: 66749145646     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2007.136580     Document Type: Review

References (116)

1. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-1801
2. Rey JR, Axon A. Budzynska A, et al. Guidelines of the European Society of Gastrointestinal Endoscopy. Antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 1998;30:318-324
3. Hirota WK, Petersen K, Baron TH, et al. Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2003;58:475-482 (Pubitemid 37205756)
4. British Society of Gastroenterology, Antibiotic prophylaxis in gastrointestinal endoscopy. http://www.bsg.org.uk/bsgdisp1.php?id= 48c1b0bcae9daa89d36a&h=1&m=00023 (accessed March 2009).
5. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 2004;25:267-276 (Pubitemid 38235165)
6. Ramsdale DR, Turner-Stokes L. Advisory Group of the British Cardiac Society Clinical Practice Committee. Prophylaxis and treatment of infective endocarditis in adults: a concise guide. Clin Med 2004;4:545-550
7. Gould FK, Elliott TSJ, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006;57:1035-1042 (Pubitemid 44644403)
8. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-1754
9. Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008;67:791-798
10. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/guidance/index.jsp?action=byID&o=11938 (accessed March 2009).
11. Richey R, Wray D, Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ 2008;336:770-771
12. Nelson DB. Infectious disease complications of GI endoscopy: Part 1: endogenous infections. Gastrointest Endosc 2003;57:546-556 (Pubitemid 36402723)
13. Bianco JA, Pepe MS, Higano C, et al. Prevalence of clinically relevant bacteraemia after upper gastrointestinal endoscopy in bone marrow transplant recipients. Am J Med 1990;89:134-136 (Pubitemid 20254435)
14. Barawi M, Gottlieb K, Cunha B, et al. A prospective evaluation of the incidence of bacteremia associated with EUS-guided fine needle aspiration. Gastrointest Endosc 2001;53:189-192 (Pubitemid 32147600)
15. Levy MJ, Norton ID, Wiersema MJ, et al. Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA. Gastrointest Endosc 2003;57:672-678 (Pubitemid 36637260)
16. Janssen J, Konig K, Knop-Hammad V, et al. Frequency of bacteremia after linear EUS of the upper GI tract with and without FNA. Gastrointest Endosc 2004;59:339-344 (Pubitemid 38337838)
17. Levy MJ, Norton ID, Clain JE, et al. Prospective study of bacteraemia and complications with EUS FNA of rectal and perirectal lesions. Clin Gastroenterol Hepatol 2007;5:684-689 (Pubitemid 46830057)
18. Seymour RA. Dentistry and the medically compromised patient. Surgeon 2003;1:207-214 (Pubitemid 36986725)
19. Roberts GJ. Dentists are innocent! "Everyday" bacteraemia is the real culprit: a review and assessment of the evidence dental surgical procedures are a principle cause of bacterial endocarditis in children. Paediatr Cardiol 1999;20:317-325
20. Vasanthakumar V, Bhan GL, Perera BS, et al. A. study to assess the efficacy of chemoprophylaxis in the prevention of endoscopy-related bacteraemia in patients aged 60 and over. Q J Med 1990;75:647-653 (Pubitemid 20214397)
21. Bayliss R, Clarke C, Oakley CM, et al. The bowel, the genitourinary tract, and infective endocarditis. Br Heart J 1984;51:339-345 (Pubitemid 14164699)
22. Yin T, Dellipiani A. Bacterial endocarditis after Hurst bougienage in a patient with a benign oesophageal stricture. Endoscopy 1983;15:27-28 (Pubitemid 13171083)
23. Niv Y, Bat L, Motro M. Bacterial endocarditis after Hurst bougienage in a patient with benign oesophageal stricture and mitral valve prolapse. Gastrointest Endosc 1985;31:265-267 (Pubitemid 15014997)
24. Breuer GS, Yinnon AM, Halevy J. Infective endocarditis associated with upper endoscopy: case report and review. J Infect 1998;36:342-344 (Pubitemid 28291492)
25. Baskin G. Prosthetic endocarditis after endoscopic variceal sclerotherapy: a failure of antibiotic prophylaxis. Am J Gastroenterol 1989;84:311-312 (Pubitemid 19081692)
26. Wong A, Rosenstein AH, Rutherford RE, et al. Bacterial endocarditis following endoscopic variceal sclerotherapy. J Clin Gastroenterol 1997;24:90-91 (Pubitemid 27142930)
27. Rumfeld W, Wallace G, Scott BB. Bacterial endocarditis after endoscopy [letter]. Lancet 1980;2:1083.
28. Logan R, Hastings J. Bacterial endocarditis: a complication of gastroscopy. Br Med J 1988;296:1107. (Pubitemid 18097376)
29. Pritchard T, Foust R, Cantey R. Prosthetic valve endocarditis due to Cardiobacterium hominis occurring after upper gastrointestinal endoscopy. Am J Med 1991;90:516-518
30. Pentimone F, Del Corso L, Borelli A, et al. Destructive endocarditis caused by Streptococcus sanguis on normal valves after gastroduodenoscopy. Min Cardioangiol 1991;39:245-249
31. Montalto M, La Regina M, Gemelli P, et al. Mitral valve endocarditis caused by Streptococcus oralis occurring after upper gastrointestinal endoscopy. Am J Gastroenterol 2002;97:2149-2150
32. Cho BC, Lee JH, Park JW, et al. Subacute bacterial endocarditis associated with upper endoscopy. Yonsei Med J 2004;45:936-940 (Pubitemid 39545385)
33. Yu-Hsien L, Te-Li C, Chien-Pi C, et al. Nosocomial acinetobacter genomic species 13 TU endocarditis following an endoscopic procedure. Intern Med 2008;47:799-802.
34. Rodriguez W, Levine JS. Enterococcal endocarditis following flexible sigmoidoscopy. West J Med 1984;140:951-953 (Pubitemid 14121244)
35. Rigilano J, Mahapatra R, Barnhill J, et al. Enterococcal endocarditis following sigmoidoscopy and mitral valve prolapse. Arch Intern Med 1984;144:850-851 (Pubitemid 14173536)
36. Greco F, Krai D, Zannetti A, et al. Bacterial endocarditis after endoscopic polypectomy. Gastroenterol Clin Biol 1986;10:609.
37. Watanakunakorn C. Streptococcus bovis endocarditis associated with villous adenoma following colonoscopy. Am Heart J 1988;116:1115-1116 (Pubitemid 18249614)
38. Norfleet R. Infectious endocarditis after fiberoptic sigmoidoscopy. J Clin Gastroenterol 1991;13:448-451
39. Millaire A, Goullard L, Leroy O, et al. Isolated tricuspid endocarditis. Apropos of a case caused by Streptococcus D bovis and faecalis occuring after coloscopy. Ann Cardiol Angeiol 1991;40:23-27
40. Giusti de Marle M, Sgreccia A, Carmenini E, et al. Infective endocarditis from Enterococcus faecalis complicating colonoscopy in Heyde's syndrome. Postgrad Med J 2004;80:619-620 (Pubitemid 39389418)
41. Heiro M, Nikoskelainen J, Engblom E, et al. Eikenella corrodens prosthetic-valve endocarditis in a patient with ulcerative colitis. Scand J Infect Dis 2000;32:324-325 (Pubitemid 30601335)
42. Avlami A, Kordossis T, Vrizidis N, et al. Lactobacillus rhamnosus endocarditis complicating colonoscopy. J Infect 2001;42:283-285 (Pubitemid 32700829)
43. Malani AM, Aronoff DM, Bradley SF, et al. Cardiobacterium hominis endocarditis: two cases and a review of the literature. Eur J Clin Microbiol Infect Dis 2006;25:587-595 (Pubitemid 44389288)
44. van der Meer JTM, van Wijk W, Thompson J, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992;339:135-139
45. Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis: analysis of 52 cases submitted to a national registry. JAMA 1983;250:2318-2322
46. Wright AJ, Wilson WR. Experimental animal endocarditis. Mayo Clin Proc 1982;57:10-14.
47. Imperiale TF, Horwitz RI. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990;88:131-136 (Pubitemid 20051783)
48. Oliver R, Roberts GJ, Hooper L. Penicillins for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev 2006;(1):CD003813.
49. Anderson DJ, Olaison L, McDonald JR, et al. Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database. Eur J Clin Microbiol Infect Dis 2005;24:665-670 (Pubitemid 41667054)
50. Olaison R, Schadeitz K. Enterococcal endocarditis in Sweden 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002;34:159-166
51. Kullman E, Borsh K, Lindrtrom E, et al. Bacteraemia following diagnostic and therapeutic ERCP. Gastrointest Endosc 1992;38:444-449
52. Sauter G, Grabein B, Huber G, et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 1990;22:164-167
53. Niederau C, Pohlmann U, Lubke H, et al. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 1994;40:645-646 (Pubitemid 24292359)
54. Deviere J, Motte S, Dumoncaue JM, et al. Septicaemia after endoscopic retrograde cholangiopancreatography. Endoscopy 1990;22:72-75
55. Alveyn CG. Antimicrobial prophylaxis during biliary endoscopic procedures. J Antimicrob Chemother 1993;31(Suppl B):101-105 (Pubitemid 23099285)
56. Byl B, Deviere J, Struelens MJ, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin Infect Dis 1995;20:1236-1240
57. Alveyn CG, Robertson DAF, Wright R, et al. Prevention of sepsis following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1991;19(Suppl C):65-70.
58. Motte S, Deviere J, Dumonceau JM, et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991;101:1374-1381
59. Harris A, Chan AC, Torres-Viera C, et al. Meta-analysis of antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999;31:718-724
60. van den Hazel SJ, Speelman P, Dankert J, et al. Piperacillin to prevent cholangitis after endoscopic retrograde cholangio-pancreatography. A randomized, controlled trial. Ann Intern Med 1996;125:442-447
61. Subhani JM, Kibbler C, Dooley JS. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999;13:103-116 (Pubitemid 29090004)
62. Llach J, Bordas JM, Almela M, et al. Prospective assessment of the role of antibiotic prophylaxis in ERCP. Hepatogastroenterology 2006;53:540-542 (Pubitemid 44386955)
63. Thompson BF, Arguedas MR, Wilcox CM. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost? Aliment Pharmacol Ther 2002;16:727-734
64. Ceyssens C, Frans JM, Christiaens PS, et al. Recommendations for antibiotic prophylaxis before ERCP: can we come to workable conclusions after review of the literature? Acta Clin Belg 2006;61:10-18.
65. Cotton PB, Connor P, Rawls E, et al. Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc 2008;67:471-475
66. Sung JJ, Lyon DJ, Suen R, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. J Antimicrob Chemother 1995;35:855-864
67. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis 2005;41:S120-6. (Pubitemid 40962482)
68. Dowidar N, Kolmos HJ, Lyon H, et al. Clogging of biliary endoprostheses. A morphologic and bacteriologic study. Scand J Gastroenterol 1991;26:1137-1144
69. Sand J, Airo I, Hiltunen KM, et al. Changes in biliary bacteria after endoscopic cholangiography and sphincterotomy. Am Surg 1992;58:324-328
70. Gopal DV, Pfau PR, Lucey MR. Endoscopic management of biliary complications after orthotopic liver transplantation. Curr Treat Options Gastroenterol 2003;6:509-515
71. Allison MC, Burroughs AK, Noone P, et al. Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study. J Hepatol 1986;3:118-122 (Pubitemid 16052763)
72. The Standards Task Force. American Society of Colon and Rectal Surgeons. Practice parameters for antibiotic prophylaxis-supporting documentation. Dis Colon Rectum 1992;35:278-285
73. Sturgis TM, Yancy W, Cole JC, et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1996;91:2301-2304 (Pubitemid 26383189)
74. Jonas SK, Neimark S, Panwalker AP. Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1985;80:438-441 (Pubitemid 15080762)
75. Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective randomized, double blind controlled trial. Ann Intern Med 1987;107:824-828
76. Preclik G, Grune S, Leser HG, et al. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxyclav before percutaneous endoscopic gastrostomy. BMJ 1999;319:881-883. (Pubitemid 29457413)
77. Gossner L, Keymling J, Hahn EG, et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Endoscopy 1999;31:119-124 (Pubitemid 29154596)
78. Akkersdijk WL, van Bergeijk JD, van Egmond T, et al. Percutaneous endoscopic gastrostomy (PEG): comparison of push and pull methods and evaluation of antibiotic prophylaxis. Endoscopy 1995;27:313-316
79. Dormann AJ, Wigginhaus B, Risius H, et al. Antibiotic prophylaxis in percutaneous endoscopic gastroscopy (PEG)-results from a prospective randomized multicenter trial. Z Gastroenterol 2000;38:229-234 (Pubitemid 30179934)
80. Panigrahi H, Shreeve DR, Tan WC, et al. Role of antibiotic prophylaxis for wound infection in percutaneous endoscopic gastrostomy (PEG): result of a prospective double-blind randomized trial. J Hosp Infect 2002;50:312-315 (Pubitemid 37554861)
81. Ahmad I, Mounchar A, Abdoolah A, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy-a prospective, randomised, double-blind trial. Aliment Pharmacol Ther 2003;18:209-215 (Pubitemid 36951657)
82. Saadeddin A, Freshwater DA, Fisher NC, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy for non-malignant conditions: a double-blind prospective randomized controlled trial. Aliment Pharmacol Ther 2005;22:565-570 (Pubitemid 41360803)
83. Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol 2000;95:3133-3136
84. Jafri NS, Mahid SS, Minor KS, et al. Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy. Aliment Pharmacol Ther 2007;25:647-656 (Pubitemid 46272515)
85. Kulling D, Sonnenberg A, Fried M, et al. Cost analysis of antibiotic prophylaxis for PEG. Gastrointest Endosc 2000;51:152-156 (Pubitemid 30094506)
86. Mukhtar S, Shaker H, Basarab A, et al. Prophylactic antibiotics and Clostridium difficile infection. J Hosp Infect 2006;64:93-94 (Pubitemid 44161387)
87. Carignan A, Allard C, Pepin J, et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008;46:1838-1843
88. Apter AJ, Kinman JL, Bilker WB, et al. Is there cross-reactivity between penicillins and cephalosporins? Am J Med 2006;119:354.e11-9
89. Mainie I, Loughrey A, Watson J, et al. Percutaneous endoscopic gastrostomy sites infected by methicillin-resistant Staphylococcus aureus: impact on outcome. J Clin Gastroenterol 2006;40:297-300. (Pubitemid 44309520)
90. Hull M, Beane A, Bowen J, et al. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther 2001;15:1883-1888 (Pubitemid 34014343)
91. Horiuchi A, Nakayama Y, Kajiyama M, et al. Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce PEG peristomal wound infection. Am J Gastroenterol 2006;101:274-277 (Pubitemid 43381667)
92. Rao GG, Osman M, Johnson L, et al. Prevention of percutaneous endoscopic gastrostomy site infections caused by methicillin-resistant Staphylococcus aureus. J Hosp Infect 2004;58:81-83 (Pubitemid 39207116)
93. Thomas S, Cantrill S, Waghorn DJ, et al. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther 2007;25:593-597 (Pubitemid 46255860)
94. Shastri YM, Hoepffner N, Tessmer A, et al. New introducer PEG gastropexy does not require prophylactic antibiotics: multicenter prospective randomized double-blind placebo-controlled study. Gastrointest Endosc 2008;67:620-628
95. Maple JT, Petersen BT, Baron TH, et al. Direct percutaneous endoscopic jejunostomy: outcomes in 307 consecutive attempts. Am J Gastroenterol 2005;100:2681-2688 (Pubitemid 43919635)
96. Bleichner G, Boulanger R, Squara P, et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986;73:724-726 (Pubitemid 16011175)
97. Ho H, Zuckerman M, Wassem C. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices. Gastroenterol 1991;101:1642-1648
98. Bernard B, Cadranel JF, Valla D, et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995;108:1828-1834
99. Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998;27:1207-1212 (Pubitemid 28227845)
100. Bernard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999;29:1655-1661 (Pubitemid 29247035)
101. Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002;(2):CD002907.
102. Jun CH, Park CH, Lee WS, et al. Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study. J Korean Med Sci 2006;21:883-890
103. Hou MC, Lin HC, Liu TT, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004;39:746-753 (Pubitemid 38337654)
104. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000;46(Suppl 3-4):1-15. (Pubitemid 30441234)
105. Fernandez J, Del Arbol L, Gomez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006;131:1049-1056 (Pubitemid 44498687)
106. Bhutani MS, Hawes RH, Baron PL, et al. Hoffman BJ. Endoscopic ultrasound guided fine needle aspiration of malignant pancreatic lesions. Endoscopy 1997;29:854-858
107. Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997;112:1087-1095 (Pubitemid 27157518)
108. Williams DB, Sahai AV, Aabakken L, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999;44:720-726 (Pubitemid 29195923)
109. Hawes RH. Endoscopic management of pseudocysts. Rev Gastroenterol Disord 2003;3:135-141 (Pubitemid 37098672)
110. Norton ID, Clain JE, Wiersema MJ, et al. Utility of endoscopic ultrasonography in endoscopic drainage of pancreatic pseudocysts in selected patients. Mayo Clin Proc 2001;76:794-798 (Pubitemid 32729478)
111. Mortensen MB, Fristrup C, Holm FS, et al. Prospective evaluation of patient tolerability, satisfaction with patient information and complications in endoscopic ultrasonography. Endoscopy 2005;37:146-153 (Pubitemid 40246504)
112. Leung JW, Ling TK, Chan RC, et al. Antibiotics, biliary sepsis and bile duct stones. Gastrointest Endosc 1994;40:716-721 (Pubitemid 24366586)
113. Sung JJ, Lyon DJ, Suen R, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomised, controlled clinical trial. J Antimicrob Chemother 1995;35:855-864
114. Mehal WZ, Culshaw KD, Tillotson GS, et al. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. Eur J Gastroenterol Hepatol 1995;7:841-845
115. Davis AJ, Kolios G, Alveyn CG, et al. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. Aliment Pharmacol Ther 1998;12:207-211 (Pubitemid 28160014)
116. Harding I, Sorgel F. Comparative pharmacokinetics of teicoplanin and vancomycin. J Chemother 2000;12(Suppl 5):15-20.